Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
10.53
+0.12 (1.15%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Assembly Biosciences Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Assembly Biosciences stock have an average target of 33, with a low estimate of 31 and a high estimate of 35. The average target predicts an increase of 213.39% from the current stock price of 10.53.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 25, 2025.
Analyst Ratings
The average analyst rating for Assembly Biosciences stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +194.40% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 24, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $2 → $35 | Hold → Strong Buy | Upgrades | $2 → $35 | +232.38% | Sep 20, 2024 |
Financial Forecast
Revenue This Year
31.61M
from 28.52M
Increased by 10.82%
Revenue Next Year
24.86M
from 31.61M
Decreased by -21.33%
EPS This Year
-5.79
from -6.69
EPS Next Year
-6.12
from -5.79
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 35.4M | 32.1M | 124.7M | ||
| Avg | 31.6M | 24.9M | 60.6M | ||
| Low | 27.7M | 17.8M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 24.1% | 1.6% | 401.5% | ||
| Avg | 10.8% | -21.3% | 143.6% | ||
| Low | -2.9% | -43.6% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -5.32 | -3.10 | 2.17 | ||
| Avg | -5.79 | -6.12 | -5.10 | ||
| Low | -6.16 | -8.87 | -11.83 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.